• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. D/B/A EV3 NEUROVASCULAR PIPELINE; INTRACRANIAL ANEURYSM FLOW DIVERTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. D/B/A EV3 NEUROVASCULAR PIPELINE; INTRACRANIAL ANEURYSM FLOW DIVERTER Back to Search Results
Model Number NV UNK PIPELINE
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Unspecified Infection (1930); Obstruction/Occlusion (2422); Pseudoaneurysm (2605)
Event Date 11/11/2021
Event Type  Injury  
Event Description
Cohen j, henkes h, gomori j, rajz g, leker r.Standalone flow diversion therapy effectively controls rebleeding of acutely ruptured internal carotid artery trunk (nonbranching) microaneurysms.Journal of clinical medicine.2021, 10, 5249.Https://doi.Org/10.3390/jcm10225249.  the purpose of this article was to review flow diversion treatment as a promising option in selected patients with acutely ruptured microaneurysms.The authors reviewed fifteen cases of patients treated for internal carotid artery (ica) microaneurysms, 13 of which used the ped pipeline stent.Of the 13 patients, the average age was 54 years, 12 were female and 1 was male.  the article does not state any technical issues during use of the pipeline.No procedural complications occurred.Immediately after fds implantation, aneurysms presented different degrees of incomplete angiographic occlusion, with o¿kelly¿marotta scores [12] of a1 in three patients, b1 in four, b2 in one, c2 in six, c3 in one.Despite consistent near-zero or incomplete angiographic exclusion, none of the aneurysms rebled during the hospital stay or follow-up.One patient developed a femoral pseudoaneurysm that was managed with percutaneous injection of thrombin.Two patients complicated with pneumonia.One patient developed symptomatic cerebral vasospasm that was refractory to conservative measures and required endovascular angioplasty.One patient died 27 days after the endovascular intervention and 3 days after transfer to rehabilitation after a suspected fulminant pulmonary embolism.  the following intra- or post-procedural outcomes were noted: 1.One patient developed a femoral pseudoaneurysm 2.Two patients complicated with pneumonia 3.One patient developed symptomatic cerebral vasospasm 4.One patient died after a suspected fulminant pulmonary embolism.
 
Manufacturer Narrative
Refer to regulatory report# 2029214-2022-00418 for related information.Cohen j, henkes h, gomori j, rajz g, leker r.Standalone flow diversion therapy effectively controls rebleeding of acutely ruptured internal carotid artery trunk (nonbranching) microaneurysms.Journal of clinical medicine.2021, 10, 5249.Https://doi.Org/10.3390/jcm10225249.The information for patient age and gender are averages from the 13 patient's in the study.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PIPELINE
Type of Device
INTRACRANIAL ANEURYSM FLOW DIVERTER
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. D/B/A EV3 NEUROVASCULAR
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. D/B/A EV3 NEUROVASCULAR
9775 toledo way
irvine CA 92618
Manufacturer Contact
glen belmer
9775 toledo way
irvine, CA 92618
6122713209
MDR Report Key13792817
MDR Text Key287803433
Report Number2029214-2022-00419
Device Sequence Number1
Product Code OUT
Combination Product (y/n)N
Reporter Country CodeIS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 03/16/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberNV UNK PIPELINE
Device Catalogue NumberNV UNK PIPELINE
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/03/2022
Initial Date FDA Received03/17/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age54 YR
Patient SexFemale
-
-